The mainstays of treatment until recently were water restriction and hypertonicsaline.
2
Therefore, we additionally started to correct hyponatremia by continuous injection of hypertonicsaline.
3
Additional study of hypertonicsaline as a diuretic adjuvant is warranted.
4
Sputum was induced by hypertonicsaline inhalation and processed using the whole sample method.
5
She was treated with a continuous infusion of hypertonicsaline.
6
Conclusion: Fluid resuscitation using hypertonicsaline results in volume expansion and less total infusion volume.
7
Objective: To better define the usage of sputum induction by hypertonicsaline in the setting of CAP.
8
We experienced a successful case of refractory congestive heart failure with hyponatremia treated with hypertonicsaline and furosemide.
9
In conclusion, the use of hypertonicsaline may have beneficial features in selected critically ill patients when carefully chosen.
10
Sparse evidence indicates that resuscitation with hypertonicsaline results in less perioperative complications, ICU days and mortality in selected patients.
11
At the same time, the discovery of nebulized hypertonicsaline enables better airway cleaning with a benefit for respiratory function.
12
We experienced a successful case of refractory congestive heart failure with hyponatremia treated with hypertonicsaline and low dose furosemide.
13
Fluid resuscitation using hypertonicsaline was used in the past for more than thirty years, but has recently disappeared from clinical practice.
14
Stroke-associated increases in lung water content were attenuated with 7.5% hypertonicsaline at all time points.
15
Conclusions: Intratesticular hypertonicsaline injection seems to be an alternative method in the future to its rivals such as orchiectomy and medical castration.
16
Methods: A retrospective analysis was performed in all patients receiving hypertonicsaline for diuretic therapy-resistant ADHF at the authors' institution since March 2013.